Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06925113 | A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan(HERGYN) | completed | — | 509 | Daiichi SankyoINDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT03839524 | A Trial Evaluating TG4050 in Ovarian Carcinoma. | completed | Phase 1 | 64 | TransgeneINDUSTRY | 2 | Nov 14, 2025 |
| clinicaltrials |
| NCT03738228 | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Nov 12, 2025 | clinicaltrials |
| NCT04272086 | Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy | completed | Phase 4 | 140 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT01676818 | Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer | completed | Phase 2 | 32 | University of Southern CaliforniaOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT02111941 | Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Early Phase 1 | 19 | Mayo ClinicOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT06861504 | The Femscope Calm Collect Device | completed | N/A | 13 | University of MichiganOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT06550791 | Evaluating the Anticancer Learning Circle Lifestyle Program in Endometrial Cancer Survivors | completed | N/A | 23 | University of VirginiaOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT03325634 | Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer | completed | Phase 1 | 15 | University of Colorado, DenverOTHER | 1 | Oct 23, 2025 | clinicaltrials |
| NCT02159989 | Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 83 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2025 | clinicaltrials |
| NCT04049227 | Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer | completed | Early Phase 1 | 27 | Northwestern UniversityOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT04386993 | De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer(DeCRESCEndo) | completed | N/A | 25 | Washington University School of MedicineOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT05247853 | HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV | completed | — | 3,127 | Montefiore Medical CenterOTHER | 1 | Oct 16, 2025 | clinicaltrials |
| NCT04025229 | High Intensity Interval Training in Endometrial Cancer | completed | N/A | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT04363957 | Gynecologic Brachytherapy-Specific Educational Video | completed | N/A | 80 | University of California, San DiegoOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT05293496 | A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors | completed | Phase 1 | 31 | MacroGenicsINDUSTRY | 1 | Oct 14, 2025 | clinicaltrials |
| NCT05523700 | Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)(VIRGO) | completed | N/A | 10 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT03776812 | Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 2 | 178 | Corcept TherapeuticsINDUSTRY | 5 | Oct 7, 2025 | clinicaltrials |
| NCT03460483 | Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care(OPTEC) | completed | N/A | 1,001 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT01935934 | Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | completed | Phase 2 | 102 | National Cancer Institute (NCI)NIH | 2 | Oct 1, 2025 | clinicaltrials |
| NCT05446870 | Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) | completed | Phase 2 | 160 | Merck Sharp & Dohme LLCINDUSTRY | 11 | Oct 1, 2025 | clinicaltrials |
| NCT07202429 | Additive Role of ADC Value to ORADS in Adnexal Lesions | completed | — | 66 | Cairo UniversityOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT05191212 | Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer | completed | N/A | 80 | Bakirkoy Dr. Sadi Konuk Research and Training HospitalOTHER_GOV | 1 | Sep 24, 2025 | clinicaltrials |
| NCT04532645 | Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK(OVAL-1) | completed | — | 342 | AstraZenecaINDUSTRY | 3 | Sep 23, 2025 | clinicaltrials |
| NCT03298893 | Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months (NiCOL)(NiCOL) | completed | Phase 1 / Phase 2 | 21 | Institut CurieOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT05736588 | Elimisha HPV (Human Papillomavirus) | completed | N/A | 982 | Duke UniversityOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04344795 | Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors | completed | Phase 1 | 89 | Tempest TherapeuticsINDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT04892342 | Study of ESG401 in Adults With Solid Tumors | completed | Phase 1 / Phase 2 | 156 | Shanghai Escugen Biotechnology Co., LtdINDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07159958 | Simulation Supported Vulva Cancer and Self-Examination on Knowledge, Skills and Attitude | completed | N/A | 94 | Trakya UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT03275506 | PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .(NEOPEMBROV) | completed | Phase 2 | 91 | ARCAGY/ GINECO GROUPOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT04908787 | A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer | completed | Phase 3 | 421 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 11, 2025 | clinicaltrials |
| NCT04374630 | Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian(PROFECTA-II) | completed | Phase 2 | 150 | Laekna LimitedINDUSTRY | 2 | Sep 10, 2025 | clinicaltrials |
| NCT04411849 | Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia | completed | N/A | 802 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT06949124 | A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects | completed | Phase 1 | 20 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 10, 2025 | clinicaltrials |
| NCT03022032 | The HOPE Trial and the SMART Study | completed | N/A | 102 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04272216 | An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres(RAVI Registry) | completed | — | 99 | Terumo Medical CorporationINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04534075 | Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial(FIDURA) | completed | Phase 3 | 354 | Sahlgrenska University HospitalOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT04646005 | Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy | completed | Phase 2 | 113 | Regeneron PharmaceuticalsINDUSTRY | 8 | Sep 8, 2025 | clinicaltrials |
| NCT00924027 | A Study of Patients Receiving High-Dose Rate Brachytherapy | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 5, 2025 | clinicaltrials |
| NCT04853017 | A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors(AMPLIFY-201) | completed | Phase 1 | 25 | Elicio TherapeuticsINDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT05742711 | Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients | completed | N/A | 48 | DyAnsys, Inc.INDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT03085225 | Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.(TRAMUNE) | completed | Phase 1 | 40 | Institut BergoniéOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT03898167 | Prospective Evaluation of Self-Testing to Increase Screening(PRESTIS) | completed | N/A | 2,474 | Baylor College of MedicineOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT07154966 | Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy(GYM-TASTE) | completed | — | 102 | Ankara Etlik City HospitalOTHER_GOV | 1 | Sep 4, 2025 | clinicaltrials |
| NCT02748460 | Non-interventional Study to Evaluate Long Term Safety, Prescription Management Patterns of Esmya in a Long Term Setting(Premium) | completed | — | 1,527 | PregLem SAINDUSTRY | 16 | Sep 2, 2025 | clinicaltrials |
| NCT02498600 | Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2025 | clinicaltrials |
| NCT03300557 | Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2025 | clinicaltrials |
| NCT05815862 | Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer | completed | Phase 2 | 29 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Aug 29, 2025 | clinicaltrials |
| NCT04772989 | A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies(ARC-12) | completed | Phase 1 | 94 | Arcus Biosciences, Inc.INDUSTRY | 3 | Aug 28, 2025 | clinicaltrials |
| NCT06192017 | Development of a Molecular Diagnostic Tool for Endometrial Cancer. | completed | — | 1,950 | MiMARK Diagnostics, S.L.INDUSTRY | 1 | Aug 28, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Nov 17, 2025source: clinicaltrials